Sustained Clinical Response with Golimumab Administered Subcutaneously Every 4 Weeks in Ankylosing Spondylitis: 104-Week Results of a Randomized, Placebo-Controlled Study
Author(s):
Braun, J.; Heijde, D. van der; Deodhar, A.; Beutler, A.; Mack, M.; Hsu, B.; Inman, R.D.
Published
2011
Publication type
Article / Letter to editor
Date issued
2011-10-31
Language
English
Is part of
Arthritis and Rheumatism (2011), Vol. 63, no. 10, p. S479-S479
